# FDA 483 - Magno-Humphries Inc. - August 06, 2025

Source: https://www.keypedia.com/records/483/magno-humphries-inc/8e6b9b01-0381-4653-b85c-6075d42109b0

> FDA 483 for Magno-Humphries Inc. on August 06, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Magno-Humphries Inc.
- Inspection Date: 2025-08-06
- Product Type: drugs
- Office Name: Seattle District Office
- Summary: An FDA inspection of Magno-Humphries Inc., an OTC Drug Repacker/Relabeler in Tigard, OR, revealed a significant quality control deficiency. The firm's quality unit failed to consistently perform required in-process quality inspections, specifically not obtaining random packaged containers three times during the packaging process as mandated by their own sampling SOP. This indicates a breakdown in adherence to established quality control procedures.

## Related Documents

- [483 - 2025-07-09](https://www.keypedia.com/records/483/magno-humphries-inc/22d474e9-ef26-4ad9-b9ee-e9d3e88e1f0c)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Thuy Tram L. Nguyen](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25)

Company: https://www.keypedia.com/companies/magno-humphries-inc/1a616827-99d0-40ca-8695-24c1aea546a4

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913